Protective effects of flavonol isoquercitrin, against 6-hydroxy dopamine (6-OHDA) - Induced toxicity in PC12 cells

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Magalingam, Kasthuri Bai ^a   Radhakrishnan, Ammu ^a   Haleagrahara, Nagaraja ^b  

^a INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

^b JAMES COOK UNIVERSITY   (Australia)

Author keywords

Antioxidant Flavonoids 6 hydroxydopamine Parkinson's disease Oxidative stress

Indexed keywords

RATTUS;

ANTIOXIDANT; CATALASE; DRUG DERIVATIVE; FREE RADICAL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; ISOQUERCITRIN; NEUROPROTECTIVE AGENT; NEUROTOXIN; OXIDOPAMINE; QUERCETIN; SUPEROXIDE DISMUTASE;

ANIMAL; ARTICLE; DOPAMINERGIC NERVE CELL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG SCREENING; IN VITRO STUDY; LIPID PEROXIDATION; METABOLISM; OXIDATIVE STRESS; PC12 CELL LINE; RAT;

ANIMALS; ANTIOXIDANTS; CATALASE; DOPAMINERGIC NEURONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; FREE RADICALS; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LIPID PEROXIDATION; NEUROPROTECTIVE AGENTS; NEUROTOXINS; OXIDATIVE STRESS; OXIDOPAMINE; PC12 CELLS; QUERCETIN; RATS; SUPEROXIDE DISMUTASE;

EID: 84892573315     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-49     Document Type: Article

References (38)

1. Alpha-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease. Covy JP, Giasson BI, Neurotoxicology 2011 2011 32 622 629
2. Initial motor symptoms of Parkinson disease. Garcia Ruiz PJ, Catalan MJ, Fernandez Carril JM, Neurologist 2011 17 18 S20
3. Assessment of Parkinson disease: what do we need to show neuroprotection? Ybot-Gorrin I, Vivancos-Matellano F, Chacón-Peña JR
4. Mechanism of 6-hydroxydopamine neurotoxicity. Glinka Y, Gassen M, Youdim MB, J Neural Transm 1997 50 55 66 10.1007/978-3-7091-6842-4-7 (Pubitemid 27055928)
5. Anti-inflammatory activity of quercetin and isoquercitrin in experimental murine allergic asthma. Rogerio AP, Kanashiro A, Fontanari C, da Silva EV, Lucisano-Valim YM, Soares EG, Faccioli LH, Inflamm Res 2007 56 402 408 10.1007/s00011-007-7005-6 18026696 (Pubitemid 350160416)
6. Isoquercitrin is the most effective antioxidant in the plant Thujaorientalis and able to counteract oxidative-induced damage to a transformed cell line (RGC-5 cells). Jung SH, Kim BJ, Lee EH, Osborne NN, Neurochem Int 2010 57 713 721 10.1016/j.neuint.2010.08.005 20708054
7. Neuroprotective therapy in Parkinson disease. Chen S, Le W, Am J Ther 2006 13 450 457
8. Disease model: Parkinson's disease. Shimohama S, Sawada H, Kitamura Y, Taniguchi T, Trends Mol Med 2003 9 360 365 10.1016/S1471-4914(03)00117-5 12928038 (Pubitemid 37040032)
9. Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. Hertog MGL, Hollman PCH, van de Putte B, J Agric Food Chem 1992 40 2379 2383 10.1021/jf00024a011
10. Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro. Mu X, He GY, Cheng Y, Li X, Xu B, Du G, Pharmacol Biochem Behav 2009 92 642 648 10.1016/j.pbb.2009.03.008 19327378
11. Flavonoids as antioxidants. Pietta PG, J Nat Prod 2000 63 1035 1042 10.1021/np9904509 10924197 (Pubitemid 30624503)
12. Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. García-Lafuente A, Guillamón E, Villares A, Rostagno MA, Martínez JA, Inflamm Res 2009 58 537 552 10.1007/s00011-009-0037-3 19381780
13. Antibacterial activity of flavonoids against methicillin-resistant Staphylococcus aureus strains. Alcaráz LE, Blanco SE, Puig ON, Tomás F, Ferretti FH, J Theor Biol 2000 205 231 240 10.1006/jtbi.2000. 2062 10873434 (Pubitemid 30662922)
14. Studies of structure activity relationship of flavonoids for the anti-allergic actions. Cheong H, Ryu SY, Oak MH, Cheon SH, Yoo GS, Kim KM, Arch Pharm Res 1998 21 478 480 10.1007/BF02974647 9875480 (Pubitemid 128661839)
15. Flavonoids as antioxidants in plants: location and functional significance. Agati G, Azzarello E, Pollastri S, Tattini M, Plant Sci 2012 196 67 76 23017900
16. Theoretical investigation of the molecular structure of the isoquercitrin molecule. Cornard JP, Boudet AC, Merlin JC, J Mol Struct 1999 508 37 49 10.1016/S0022-2860(99)00004-6 (Pubitemid 29444681)
17. Effects of hyperin, isoquercitrin and quercetin on lipopolysaccharide induced nitrite production in rat peritoneal macrophages. Lee S, Park HS, Notsu Y, Ban HS, Kim YP, Ishihara K, Hirasawa N, Jung SH, Lee YS, Lim SS, Park EH, Shin KH, Seyama T, Hong J, Ohuchi K, Phytother Res 2008 22 1552 1556 10.1002/ptr.2529 18814209 (Pubitemid 352789629)
18. Diuretic and potassium-sparing effect of isoquercitrin-An active flavonoid of Tropaeolummajus L. Gasparotto A Jr, Gasparotto FM, Boffo MA, Lourenço EL, Stefanello ME, Salvador MJ, da Silva-Santos JE, Marques MC, Kassuya CA, J Ethnopharmacol 2011 134 210 215 10.1016/j.jep.2010.12.009 21163342
19. Oxidative damage in neurodegenerative disease. Jenner P, Lancet 1994 344 796 798 10.1016/S0140-6736(94)92347-7 7916079 (Pubitemid 24283963)
20. Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis. Walkinshaw G, Waters CM, Neuroscience 1994 63 975 987 10.1016/0306-4522(94)90566-5 7535401 (Pubitemid 24366149)
21. Reactive oxygen species in health and disease. Datta K, Sinha S, Chattopadhyay P, Natl Med J India 2000 13 6 304 310 11209486
22. Parkinson's disease: mechanisms and models. Dauer W, Przedborski S, Neuron 2003 39 889 909 10.1016/S0896-6273(03)00568-3 12971891 (Pubitemid 37130207)
23. Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier. Gilgun-Sherki Y, Melamed E, Offen D, Neuropharmacol 2001 40 959 975 10.1016/S0028-3908(01)00019-3 (Pubitemid 32530602)
24. The neuroprotective potential of flavonoids: a multiplicity of effects. Vauzour D, Vafeiadou K, Rodriguez-Mateos A, Rendeiro C, Spencer JP, Genes Nutr 2008 3 115 126 10.1007/s12263-008-0091-4 18937002
25. Comparative effects of total flavonoids extracted from Ribesnigrum leaves, rutin and isoquercitrin on biosynthesis and release of prostaglandins in the ex vivo rabbit heart. Chanh PH, Ifansyah N, Chahine R, Mounayar-Chalfoun A, Gleye J, Moulis C, Prostaglandins Leukot Med 1986 22 295 300 10.1016/0262-1746(86)90140-X 3460101 (Pubitemid 16047578)
26. Free radicals, antioxidants and functional foods: Impact on human health. Lobo V, Patil A, Phatak A, Chandra N, Pharma Rev 2010 4 118 126 10.4103/0973-7847.70902
27. Olanzapine protects PC12 cells from oxidative stress induced by hydrogen peroxide. Wei Z, Bai OJ, Richardson S, Mousseau DD, Li XM, J Neurosci Res 2003 73 364 368 10.1002/jnr.10668 12868070 (Pubitemid 36918100)
28. Oxidative stress and gene regulation. Allen RG, Tresini M, Free Radic Biol Med 2000 28 463 499 10.1016/S0891-5849(99)00242-7 10699758 (Pubitemid 30110662)
29. Oxidative damage in the central nervous system: protection by melatonin. Reiter RJ, Prog Neurobiol 1998 56 359 384 10.1016/S0301-0082(98)00052-5 9770244 (Pubitemid 28389724)
30. Stabilization of quaternary structure and activity of bovine liver catalase through encapsulation in liposomes. Yoshimoto M, Sakamoto H, Yoshimoto N, Kuboi R, Nakao K, Enzyme Microb Technol 2007 41 6 849 858 (Pubitemid 47361335)
31. Comparative study of catalase-peroxidases (KatGs). Singh R, Wiseman B, Deemagarn T, Jha V, Switala J, Loewen PC, Arch Biochem Biophys 2008 471 207 214 10.1016/j.abb.2007.12.008 18178143
32. The neuroprotective effects of cocoa flavanol and its influence on cognitive performance. Nehlig A, Br J Clin Pharmacol 2013 75 716 727 22775434
33. Antioxidant enzymes and human diseases. José MM, Cristina PM, Ignacio ND, Clin Biochem 1999 32 595 603 10.1016/S0009-9120(99)00075-2 10638941 (Pubitemid 30039087)
34. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Blum D, Torch S, Lambeng N, Nissou M, Alim-Louis B, Sadoul R, Verna J, Prog Neurobiol 2001 65 135 172 10.1016/S0301-0082(01)00003-X 11403877 (Pubitemid 32524182)
35. Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells. Niedernhofer LJ, Daniels JS, Rouzer CA, Greene RE, Marnett LJ, J Biol Chem 2003 278 31426 31433 10.1074/jbc.M212549200 12775726 (Pubitemid 36994664)
36. Differential expression of copper-zinc superoxide dismutase gene of Polygonumsibiricum leaves, stems and underground stems, subjected to high-salt stress. Qu CP, Xu ZR, Liu GJ, Liu C, Li Y, Wei ZG, Liu GF, Int J Mol Sci 2010 11 5234 5245 10.3390/ijms11125234 21614204
37. Effect of quercetin and desferrioxamine on 6-hydroxydopamine (6-OHDA) induced neurotoxicity in striatum of rats. Haleagrahara N, Siew CJ, Kumar P, J Toxicol Sci 2013 38 25 33 10.2131/jts.38.25 23358137
38. Possible involvement of catalase in the protective effects of interleukin-6 against 6-hydroxydopamine toxicity in PC12 cells. Yamada K, Umegaki H, Iguchi A, Kameyama T, Nabeshima T, Brain Res Bull 1997 46 573 577 (Pubitemid 27318468)